Cardiac implantable electronic devices and bloodstream infections: management and outcomes.

ABSTRACT:

Background and aims

Bloodstream infection (BSI) of any cause may lead to device infection in cardiac implantable electronic device (CIED) patients. Aiming for a better understanding of the diagnostic approach, treatment, and outcome, patients with an implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy and defibrillator (CRT-D) hospitalized with BSI were investigated.

Methods

This is a single-centre, retrospective, cohort analysis including consecutive ICD/CRT-D patients implanted between 2012 and 2021. These patients were screened against a list of all hospitalized patients having positive blood cultures consistent with diagnosed infection in any department of a local public hospital.

Results

The total cohort consisted of 515 patients. O

SUBMITTER: Ozkartal T 

PROVIDER: S-EPMC10998729 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature